CA2015291A1 - Reticulum endoplasmique macromoleculaire - Google Patents

Reticulum endoplasmique macromoleculaire

Info

Publication number
CA2015291A1
CA2015291A1 CA2015291A CA2015291A CA2015291A1 CA 2015291 A1 CA2015291 A1 CA 2015291A1 CA 2015291 A CA2015291 A CA 2015291A CA 2015291 A CA2015291 A CA 2015291A CA 2015291 A1 CA2015291 A1 CA 2015291A1
Authority
CA
Canada
Prior art keywords
endoplasmic reticulum
macromolecular endoplasmic
macromolecular
polymerizable
hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015291A
Other languages
English (en)
Other versions
CA2015291C (fr
Inventor
Etsuo Hasegawa
Shinji Takeoka
Hiroyuki Ohno
Hiroyuki Nishide
Eishun Tsuchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
Nippon Oil and Fats Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2033256A external-priority patent/JPH03291216A/ja
Application filed by Nippon Oil and Fats Co Ltd filed Critical Nippon Oil and Fats Co Ltd
Publication of CA2015291A1 publication Critical patent/CA2015291A1/fr
Application granted granted Critical
Publication of CA2015291C publication Critical patent/CA2015291C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1273Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CA002015291A 1989-04-27 1990-04-24 Reticulum endoplasmique macromoleculaire Expired - Fee Related CA2015291C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11068289 1989-04-27
JP1-110682 1989-04-27
JP2033256A JPH03291216A (ja) 1989-04-27 1990-02-14 高分子小胞体
JP2-33256 1990-02-14

Publications (2)

Publication Number Publication Date
CA2015291A1 true CA2015291A1 (fr) 1990-10-27
CA2015291C CA2015291C (fr) 1996-04-30

Family

ID=26371932

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015291A Expired - Fee Related CA2015291C (fr) 1989-04-27 1990-04-24 Reticulum endoplasmique macromoleculaire

Country Status (5)

Country Link
US (1) US5160740A (fr)
EP (1) EP0395382B1 (fr)
CN (1) CN1037492C (fr)
CA (1) CA2015291C (fr)
DE (1) DE69006896T2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04283207A (ja) * 1991-03-13 1992-10-08 Kao Corp ベシクル及び重合体ベシクル
CA2121129A1 (fr) * 1991-10-29 1993-05-13 Patrick Soon-Shiong Polysaccharides pouvant etre reticules, polycations et lipides, utiles pour l'encapsulation et la liberation controlee de medicaments
DE69420876T2 (de) * 1993-03-18 2000-04-20 Terumo K.K. Liposom mit eingekapseltem Hämoglobin sowie Verfahren zu dessen Herstellung
DE4312970A1 (de) * 1993-04-21 1994-10-27 Juergen Dr Schrezenmeir Mikrokapsel sowie Verfahren und Vorrichtung zu ihrer Herstellung
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
WO1995003035A1 (fr) * 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Liposomes polymerises presentant une stabilite amelioree et s'administrant oralement
US5674528A (en) * 1994-06-15 1997-10-07 Terumo Kabushiki Kaisha Hemoglobin-encapsulated liposome
JP3532692B2 (ja) * 1995-04-03 2004-05-31 日本油脂株式会社 ホスホリルコリン基含有重合体水性溶液および製造方法
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US6187335B1 (en) 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
EP1460992B1 (fr) * 2001-12-03 2009-03-11 Dor Biopharma, Inc. Compositions a base de micelles inverses et applications
US20060210549A1 (en) * 2004-09-10 2006-09-21 Srivastava Devendra K Controlled release liposomes and methods of use
US20080094573A1 (en) * 2006-04-04 2008-04-24 Vermette Patrick Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0032622B1 (fr) * 1979-12-20 1985-08-14 Dennis Chapman Phospholipides polymérisables et leurs polymères, procédés pour leur préparation, procédés pour leur utilisation dans le revêtement de substrats et la formation de liposomes et substrats revêtus et compositions de liposomes ainsi obtenus
US4933114A (en) * 1980-08-11 1990-06-12 Eastman Kodak Company Polyacetylenic lipids, radiation-sensitive compositions, photographic elements and processes relating to same
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
GB2140806B (en) * 1983-05-28 1987-10-28 Sekimoto Hiroshi Stabilisation of unsaturated fatty acids, fish oils or fish
US4560599A (en) * 1984-02-13 1985-12-24 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
AU559292B2 (en) * 1984-12-28 1987-03-05 Terumo Kabushiki Kaisha Polymerisable liposome-forming lipids
US4990291A (en) * 1986-04-15 1991-02-05 The United States Of America As Represented By The Secretary Of The Navy Method of making lipid tubules by a cooling process
JPS638391A (ja) * 1986-06-27 1988-01-14 Terumo Corp 重合性β−グリセロリン脂質およびその製造方法
US4877501A (en) * 1987-02-06 1989-10-31 Schnur Joel M Process for fabrication of lipid microstructures
US5004566A (en) * 1987-02-06 1991-04-02 Geo-Centers, Inc. Process for fabrication of lipid microstructures from dry organic solvent
JPH01180245A (ja) * 1988-01-12 1989-07-18 Terumo Corp リポソーム
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
DE19726796A1 (de) * 1997-06-24 1999-01-07 Basf Ag Propylenpolymerisate

Also Published As

Publication number Publication date
EP0395382A3 (fr) 1991-10-30
US5160740A (en) 1992-11-03
CA2015291C (fr) 1996-04-30
DE69006896D1 (de) 1994-04-07
CN1037492C (zh) 1998-02-25
DE69006896T2 (de) 1994-08-18
EP0395382B1 (fr) 1994-03-02
EP0395382A2 (fr) 1990-10-31
CN1047312A (zh) 1990-11-28

Similar Documents

Publication Publication Date Title
CA2015291A1 (fr) Reticulum endoplasmique macromoleculaire
AU622967B2 (en) Process for micro-encapsulation
HRP940723B1 (en) New thienylcarboxylic acid esters of aminoalcohols, their quarternary products, their preparation and use of the compounds
IL79356A0 (en) 1-substituted oxindole-3-carboxamides,their preparation and pharmaceutical compositions containing them
HUT43488A (en) Process for preparing polymers decomposing by biological process and utilizable for pharmaceutical purposes
CA2059288A1 (fr) Molecules amphiphiles a proprietes tensio-actives qui contiennent du fluor et du phosphore
CA2185119A1 (fr) Forme galenique pour l'administration d'un medicament dans une formulation liquide
EP0404283A3 (fr) 11-Bêta-aryl-4-estrène, son procédé de préparation et son application comme médicament
FR2508797B1 (fr) Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
EP0451750A3 (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients
AU6732190A (en) Use of guanidinoacetic acid to induce an increase of the creatine contents in muscles
AU3927189A (en) N-2,3-butadienyl tri- and tetraaminoalkane derivatives
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
ATE55250T1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
ATE44950T1 (de) Polyprenylverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
CA2064476A1 (fr) Preparation a base de podophyllotoxine et de triglycerides
AU2921789A (en) Compounds
EP0314042A3 (fr) Copolymères et superoxyde dismutase modifiée à l'aide de ces copolymères
EP0367302A3 (fr) Procédé pour la semi-synthèse d'insuline humaine protéase I d'Achromobacter réticulée soluble dans l'eau pour sa mise en oeuvre et procédé pour la préparation de celle-ci
AU3448189A (en) Process for inhibiting the polymerization of acid monomers
TW246642B (en) Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme
AU7147787A (en) Pharmaceutical compositions of an hydroxyethyl starch and a nootropic drug
SU1120679A1 (ru) Способ получения гемосовместимых полимерных материалов
IE880226L (en) 2-(2,2-difluorocyclopropyl) alkyl esters
AU5835090A (en) Novel cyclic anthranilic acid derivatives and process of preparing the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed